# Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer

> **NCT05780684** · NA · RECRUITING · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 36 (estimated)

## Conditions studied

- Colorectal Cancer
- Esophagus Cancer
- Appendix Cancer
- Small Bowel Cancer
- Ampullary Cancer

## Interventions

- **OTHER:** FOX dose-escalation algorithm

## Key facts

- **NCT ID:** NCT05780684
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-14
- **Primary completion:** 2026-09
- **Final completion:** 2026-12
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05780684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05780684, "Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05780684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*